This article focuses on the nose as an accessible organ for research purposes, exploring whether the nose can be used to study lower airway processes.
Get full access to this article
View all access options for this article.
References
1.
HornB.R., RobinE.D., TheodoreJ., KesselA.V.Total eosinophil counts in the management of bronchial asthma.N Engl J Med292: 1152–1155, 1975.
2.
TaylorK.J., LukszaA.R.Peripheral blood eosinophil counts and bronchial responsiveness.Thorax42: 452–456, 1987.
3.
OhashiY., MotojimaS., FukudaT., MakinoS.Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial asthma.Am Rev Respir Dis145: 1469–1476, 1992.
4.
KlementssonH., VengeP., AndersonM., PipkornU.Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. In: KlementssonH., Ed. Eosinophil granulocytes and nasal responsiveness: A study of the allergic inflammatory reaction in the human nasal mucosa. Thesis. Lund, Sweden, 1991.
5.
AnderssonM., AnderssonP., VengeP., PipkornU.Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced nasal hyperresponsiveness: Effect of topical glucocorticosteroid treatment.Allergy44: 342–348, 1989.
6.
Gerth van WijkR., ZijlstraF.J., van ToorenenbergenA.W.An isolated early response after nasal allergen challenge is sufficient to induce nasal hyperreactivity.Ann Allergy69: 43–47, 1992.
7.
Gerth van WijkR., van ToorenenbergenA.W., ZijlstraF.J.Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract.Allergy Proc14: 273–281, 1993.
8.
de Graaf-in't VeldC., GarreldsI.M., van ToorenenbergenA.W., Gerth van WijkR.Nasal responsiveness to allergen and histamine in patients with perennial allergic rhinitis with and without a late phase reaction.Thorax52: 143–148, 1997.
9.
de Graaf-in ‘t VeldC., GarreldsI.M., KoendersS., Gerth van WijkR.Relationships between nasal hyperreactivity, mediators, and eosinophils in patients with perennial allergic rhinitis and controls.Clin Exp Allergy26: 903–909, 1996.
10.
de Graaf-in ‘t VeldC., GarreldsI.M., JansenA.P.H., van ToorenenbergenA.W., MulderP.G.H., MeeuwisJ., Gerth van WijkR.Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with house dust mite allergy.Clin Exp Allergy25: 966–973, 1995.
11.
GarreldsI.M., de Graaf-in ‘t VeldC., JansenA.P.H., Gerth van WijkR.Effect of fluticasone propionate aqueous nasal spray treatment on platelet activating factor and eiconasoid production by nasal mucosa in patients with house dust mite allergy.Mediators of Inflammation3: 381–385, 1994.
12.
GarreldsI.M., de Graaf-in ‘t VeldC., NahoriM.A., VargaftigB., Gerth van WijkR.Interieukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients.Eur J Pharmacol275: 295–300, 1995.
13.
de Graaf-in ‘t VeldC., GarreldsI.M., van ToorenenbergenA.W., MulderP.G.H., Gerth van WijkR.Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.Ann Allergy Asthma Immunol75: 261–266, 1995.
14.
GarreldsI.M., de Graaf-in't VeldC., van ToorenenbergenA.W., Gerth van WijkR.Selective effect of levocabastine on histamine receptor and histamine release from human leucocytes and guinea pig isolated tissue.Ann Allergy Asthma Immunol76: 327–334, 1996.
15.
GarreldsI.M., van AmsterdamJ.G.C., de Graaf-in ‘t VeldC., Gerth van WijkR.Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.Thorax50: 275–279, 1995.
16.
JuniperE.F., GuyattG.H.Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.Clin Exp Allergy21: 77–83, 1991.
17.
BousquetJ., BullingerM., FayolC.Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 health Status Questionnaire.J Allergy Clin Immunol94: 182–188, 1994.
18.
JuniperE.F., GuyattG.H., DolovichJ.Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials.J Allergy Clin Immunol93: 413–423, 1994.
19.
de Graaf-in ‘t VeldC., KoendersS., GarreldsI.M., Gerth van WijkR.The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis.J Allergy Clin Immunol98: 508–513, 1996.
